Purpose: The purpose of this study was to evaluate the early and midterm results of superficial femoral artery (SFA) stenting with self-expanding nitinol stents and to identify the factors affecting patency.
Materials And Methods: SFA stenting was performed in 165 limbs of 117 patients from January 2009 to December 2013. Patients were followed-up for the first occurrence of occlusion or stenosis based on computed tomography and duplex scan results and a decrease in ankle brachial index of >15%.
Results: During the follow-up period (mean, 15.3±3.2 months), no early thrombotic reocclusions occurred within 30 days, but in-stent restenosis developed in 78 limbs. The primary patency rates at 6, 12, 18, and 24 months were 78%, 66%, 42%, and 22%, respectively, and the secondary patency rates were 85%, 72%, 58%, and 58%, respectively. TASC II C or D lesions, stent length >8 cm, number of patent tibial arteries and diabetes were significantly associated with reintervention.
Conclusion: The midterm results of stenting for SFA occlusive disease were disappointing because the primary and secondary patency rates at two years were 22% and 58%, respectively. Reintervention after SFA stenting remains a major problem, particularly in patients with diabetes mellitus or long TASC II C or D lesions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694182 | PMC |
| http://dx.doi.org/10.5758/vsi.2015.31.4.115 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Giant aneurysmal degeneration after subintimal fluoropolymer-coated paclitaxel-eluting stent implantation for the superficial femoral artery occlusion: a case report.
Eur Heart J Case Rep
December 2024
Department of Cardiology, Ishikawa Prefectural Central Hospital, 2-1, Kuratsuki-higashi Kanazawa, Ishikawa 920-8530, Japan.
Article Synopsis
- - Drug-eluting therapies, especially the Eluvia stent, have significantly reduced restenosis rates in treating peripheral artery disease, but concerns over aneurysm formation following their use are emerging.
- - An 80-year-old man developed a giant aneurysm 27 months after receiving the Eluvia stent for a blocked artery, which was identified through ultrasound and treated with endovascular-covered stents.
- - The presence of a 'low echoic area' near the stent is a common ultrasound finding after Eluvia implantation; while typically benign for two years, it can lead to serious complications like aneurysms due to factors such as overlapping stents and mechanical stress.
Endovascular therapy via a femoro-femoral crossover bypass graft for chronic total occlusion of the superficial femoral artery: Two case reports.
SAGE Open Med Case Rep
November 2024
Department of Cardiovascular Medicine, Asahi General Hospital, Asahi, Chiba, Japan.
In patients with a femoropopliteal chronic total occlusion (CTO) after femoro-femoral (FF) bypass surgery, it is often difficult to perform endovascular therapy because of access site problems. We have treated two patients with CTO of the superficial femoral artery (SFA) using an FF crossover bypass graft. The two cases were a man with intermittent claudication and acute limb ischemia, respectively.
View Article and Find Full Text PDFLaser Atherectomy and Restenting of the Superficial Femoral Artery Using GORE VIABAHN Endoprosthesis Following Failure of Both Bare-Metal Stenting and Surgical Revascularization.
Case Rep Vasc Med
November 2024
Department of Cardiology, Methodist Le Bonheur Healthcare, Memphis, Tennessee, USA.
Peripheral arterial disease (PAD) affects more than 230 million adults worldwide. Revascularization via angioplasty is a common method to manage stenosis in the superficial femoral artery (SFA). In-stent restenosis, however, is a common complication in endovascular interventions, especially in the SFA.
View Article and Find Full Text PDFThree-Year Safety and Efficacy of Endovascular Treatment of Common Femoral Artery in 150 PAD Patients.
Biomedicines
September 2024
Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University of Duesseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany.
Article Synopsis
- The study evaluated three-year outcomes of endovascular treatment (EVT) for peripheral arterial disease (PAD) in patients with severe calcified lesions in the common femoral artery (CFA), using data from the Duesseldorf PTA Registry.
- A total of 150 patients were analyzed, with 66 undergoing rotational excisional atherectomy (REA) followed by drug-coated balloon (DCB) angioplasty, and 84 receiving DCB alone; the procedural success rate was high at 97%.
- Findings indicated that EVT is safe and effective, showing high primary and secondary patency rates, low major adverse limb events (MALEs), and major adverse cardiovascular events (MACEs) after three years, suggesting that RE
Swirling Flow Quantification in Helical Stents Using Ultrasound Velocimetry.
J Endovasc Ther
October 2024
Multi-Modality Medical Imaging, Technical Medical (TechMed) Centre, University of Twente, Enschede, The Netherlands.
Objective: Helical stents have been developed to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA), with the premise that their particular geometry could promote swirling flow in the blood. The aim of this work is to provide evidence on the existence of this swirling flow by quantifying its signatures.
Materials And Methods: This study consists of in vitro and in vivo parts.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!